查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609149

被忽视的热带疾病治疗市场：按产品类型、疾病类型、诊断方法划分 - 全球预测 2025-2030

Neglected Tropical Disease Treatment Market by Product (Drugs, Vaccines), Types of Diseases (Buruli Ulcer, Chagas Disease, Dengue), Diagnostic Method - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

被忽视的热带疾病治疗市场2023年估值为61.3亿美元，预计到2024年将达到64亿美元，复合年增长率为6.25%，预计到2030年将达到93.8亿美元。

被忽视的热带疾病（NTD）是一组主要影响热带地区贫困阶级并导致严重发病和社会耻辱的疾病。治疗被忽视的热带疾病需要采取综合方法，因为它对人们的健康、经济生产力和社会结构有重大影响。这些措施包括医疗介入、病媒控制、公共卫生宣传活动和社区教育。这包括疫苗、治疗学和诊断工具中的应用。最终用途范围从政府卫生机构到非营利组织再到参与药物开发和分销的私人公司。市场成长受到认识提高、流行地区医疗基础设施改善以及促进药物研究和生产的官民合作关係关係的影响。潜在的商机在于药物发现技术的进步、国际组织增加的投资以及扩大覆盖范围和客製化治疗的策略联盟。为了利用这些优势，相关人员应专注于加强研发能力，加强跨部门合作，并利用数位健康技术进行有效的疾病追踪和病患管理。

主要市场统计
基准年[2023] 61.3亿美元
预计年份 [2024] 64亿美元
预测年份 [2030] 93.8亿美元
复合年增长率（%） 6.25%

然而，该市场面临基础设施薄弱、资金不足和严格的监管控制等限制，阻碍了药物的快速核准和分销。受被忽视热带疾病影响最严重的地区的政治不稳定使干预措施更加复杂。创新研究可以专注于开发综合方法，将病原体基因组学结合起来进行个人化医疗、提高可及性的新药物输送系统以及治疗和预防措施。您可以透过探索具有成本效益的生产技术和本地製造解决方案来减少对国际供应链的依赖，从而加速业务成长。 NTD 治疗市场的本质是动态的，与医疗保健的进步和全球政策转变相交叉，需要灵活的策略来应对不断变化的挑战。为了实现永续成长和影响力，进入开拓的公司必须跟上技术创新的步伐，加强国际合作，并开发适合当地需求和环境的产品和服务。

市场动态：针对快速发展的被忽视的热带疾病治疗市场揭示的关键市场见解

供需的动态交互作用正在改变被忽视的热带疾病治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 人们对被忽视的热带疾病治疗的认识不断提高
    • 热带和亚热带国家被忽视的热带疾病负担日益加重
    • 研发投入庞大
  • 市场限制因素
    • 药物副作用
  • 市场机会
    • 政府的优惠待遇
    • 增加研发投资并推出新的治疗方案
  • 市场挑战
    • 缺乏标准化的诊断和治疗工具

波特的五力：驾驭被忽视的热带疾病治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对被忽视的热带疾病治疗市场的影响

外部宏观环境因素在塑造被忽视的热带疾病治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解被忽视的热带疾病治疗市场的竞争格局

对被忽视的热带疾病治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 在被忽视的热带疾病治疗市场中的定位矩阵供应商绩效评估

FPNV 定位矩阵是评估被忽视的热带疾病治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了被忽视的热带疾病治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，被忽视的热带疾病治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人们越来越认识到被忽视的热带疾病的治疗方法
      • 热带和亚热带国家经常被忽视的热带疾病的负担增加
      • 庞大资金投入研发
    • 抑制因素
      • 药物副作用
    • 机会
      • 政府的优惠待遇
      • 加大研发投入并推出新的治疗方案
    • 任务
      • 缺乏标准化的诊断和治疗工具
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章被忽视的热带疾病治疗市场：副产品

  • 药物
  • 疫苗

第七章依疾病类型分類的被忽视的热带疾病治疗市场

  • 布鲁里溃疡
  • 南美锥虫病
  • 登革热
  • 人类非洲锥虫病
  • 利什曼原虫症
  • 麻风
  • 狂犬病
  • 土源性蠕虫病
  • 沙眼
  • 草莓瘤

第八章 诊断方法被忽视的热带疾病治疗市场

  • 传统的
  • 分子/现代

第九章 美洲被忽视的热带疾病治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区被忽视的热带疾病治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲被忽视的热带疾病治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amneal Pharmaceuticals LLC
  • Bayer AG
  • Daiichi Sankyo Company, Limited
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Insud Pharma, SL
  • Novartis AG
  • Oblita Therapeutics
  • Omega Diagnostics Group PLC
  • Oscar Medicare Pvt Ltd.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Themis Bioscience GmbH
  • Valneva SE
  • ZeptoMetrix, LLC
Product Code: MRR-AD36CD897E7F

The Neglected Tropical Disease Treatment Market was valued at USD 6.13 billion in 2023, expected to reach USD 6.40 billion in 2024, and is projected to grow at a CAGR of 6.25%, to USD 9.38 billion by 2030.

Neglected Tropical Diseases (NTDs) encompass a group of conditions primarily affecting impoverished populations in tropical regions, resulting in significant morbidity and social stigma. NTD treatment necessitates comprehensive efforts due to their profound impact on human health, economic productivity, and social structure. The scope encompasses medical intervention, vector control, public health campaigns, and community education. Applications include use in vaccines, therapeutic drugs, and diagnostic tools. End-use ranges from governmental health agencies to non-profits and private sector players involved in drug development and distribution efforts. Market growth is influenced by increased awareness, improved healthcare infrastructure in endemic regions, and public-private partnerships fostering pharmaceutical research and production. Potential opportunities lie in technological advancements in drug discovery, rising investments from international organizations, and strategic alliances aimed at broader coverage and tailored treatments. To capitalize on these, stakeholders should focus on enhancing R&D capabilities, reinforcing collaborations across sectors, and leveraging digital health technologies for efficient disease tracking and patient management.

KEY MARKET STATISTICS
Base Year [2023] USD 6.13 billion
Estimated Year [2024] USD 6.40 billion
Forecast Year [2030] USD 9.38 billion
CAGR (%) 6.25%

However, the market faces limitations due to infrastructural inadequacies, low funding, and stringent regulatory controls, which hinder swift drug approval and distribution. Political instability in regions most affected by NTDs further complicates efforts to deliver interventions. Innovative research can focus on pathogen genomics for personalized medicine, novel drug delivery systems to improve accessibility, and developing integrated approaches combining treatment with preventive measures. Business growth can be bolstered by exploring cost-effective production technologies and localized manufacturing solutions to reduce dependency on international supply chains. The nature of the NTD treatment market is dynamic, driven by the intersection of healthcare advances and global policy shifts, requiring agile strategies to address evolving challenges. Market players are advised to stay abreast of technological innovations, strengthen international collaborations, and adopt a bottom-up approach in developing products and services aligned with local needs and conditions, to achieve sustainable growth and impact.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neglected Tropical Disease Treatment Market

The Neglected Tropical Disease Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising awareness of neglected tropical diseases treatments
    • Increasing burden of neglected tropical disease in tropical and subtropical countries
    • Huge financial investment in research & development
  • Market Restraints
    • Side effects of the drugs
  • Market Opportunities
    • Favorable government initiatives for the treatment
    • Increasing investments in R&D and new launches in the treatment programs
  • Market Challenges
    • Lack of standardization tools for diagnosis and treatment

Porter's Five Forces: A Strategic Tool for Navigating the Neglected Tropical Disease Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neglected Tropical Disease Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neglected Tropical Disease Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neglected Tropical Disease Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neglected Tropical Disease Treatment Market

A detailed market share analysis in the Neglected Tropical Disease Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neglected Tropical Disease Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neglected Tropical Disease Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neglected Tropical Disease Treatment Market

A strategic analysis of the Neglected Tropical Disease Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neglected Tropical Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include Amneal Pharmaceuticals LLC, Bayer AG, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, Insud Pharma, S.L., Novartis AG, Oblita Therapeutics, Omega Diagnostics Group PLC, Oscar Medicare Pvt Ltd., Sanofi S.A, Teva Pharmaceutical Industries Ltd, Themis Bioscience GmbH, Valneva SE, and ZeptoMetrix, LLC.

Market Segmentation & Coverage

This research report categorizes the Neglected Tropical Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Drugs and Vaccines.
  • Based on Types of Diseases, market is studied across Buruli Ulcer, Chagas Disease, Dengue, Human African trypanosomiasis, Leishmaniases, Leprosy, Rabies, Soil-transmitted Helminthiases, Trachoma, and Yaws.
  • Based on Diagnostic Method, market is studied across Conventional and Molecular/Modern.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness of neglected tropical diseases treatments
      • 5.1.1.2. Increasing burden of neglected tropical disease in tropical and subtropical countries
      • 5.1.1.3. Huge financial investment in research & development
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of the drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives for the treatment
      • 5.1.3.2. Increasing investments in R&D and new launches in the treatment programs
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization tools for diagnosis and treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neglected Tropical Disease Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Drugs
  • 6.3. Vaccines

7. Neglected Tropical Disease Treatment Market, by Types of Diseases

  • 7.1. Introduction
  • 7.2. Buruli Ulcer
  • 7.3. Chagas Disease
  • 7.4. Dengue
  • 7.5. Human African trypanosomiasis
  • 7.6. Leishmaniases
  • 7.7. Leprosy
  • 7.8. Rabies
  • 7.9. Soil-transmitted Helminthiases
  • 7.10. Trachoma
  • 7.11. Yaws

8. Neglected Tropical Disease Treatment Market, by Diagnostic Method

  • 8.1. Introduction
  • 8.2. Conventional
  • 8.3. Molecular/Modern

9. Americas Neglected Tropical Disease Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neglected Tropical Disease Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neglected Tropical Disease Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amneal Pharmaceuticals LLC
  • 2. Bayer AG
  • 3. Daiichi Sankyo Company, Limited
  • 4. Eisai Co., Ltd.
  • 5. F. Hoffmann-La Roche Ltd
  • 6. Insud Pharma, S.L.
  • 7. Novartis AG
  • 8. Oblita Therapeutics
  • 9. Omega Diagnostics Group PLC
  • 10. Oscar Medicare Pvt Ltd.
  • 11. Sanofi S.A
  • 12. Teva Pharmaceutical Industries Ltd
  • 13. Themis Bioscience GmbH
  • 14. Valneva SE
  • 15. ZeptoMetrix, LLC

LIST OF FIGURES

  • FIGURE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEGLECTED TROPICAL DISEASE TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY BURULI ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY HUMAN AFRICAN TRYPANOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LEISHMANIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LEPROSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY SOIL-TRANSMITTED HELMINTHIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TRACHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY YAWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MOLECULAR/MODERN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023